by RxTarget.hu | Apr 16, 2020 | Publications
Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma Lajos Géczi, György Bodoky, György Rokszin, Ibolya Fábián, László Torday (Pathology & Oncology Research,...
by RxTarget.hu | Jan 2, 2020 | Publications
Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study (Arch Med Sci 2020; 16 (1): 34–41) László Barkai, Zoltán Kiss, György Rokszin, Zsolt...
by RxTarget.hu | Oct 23, 2019 | Publications
Frontiers in Oncology Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi,...
by RxTarget.hu | Jul 27, 2019 | Publications
Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016: A nationwide cohort study György Jermendy, Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, István Wittmann, Péter Kempler (Diabetes Research and Clinical Practice 155...
by RxTarget.hu | Jun 22, 2019 | Publications
Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: A nationwide analysis in Hungary Zoltán Kiss, György Rokszin, Zsolt Abonyi‐Tóth, György Jermendy, Péter Kempler, László Barkai, István Wittmann...
by RxTarget.hu | May 2, 2019 | Publications
The impact of bleeding and comorbidities on the risk of mortality in patients with atrial fibrillation Robert Kiss, Daniel Aradi, Gyorgy Rokszin, Ibolya Fabian, Csaba Andras Dezsi and Bela Merkely (Volume 73, Issue 9 Supplement 1, March 2019, DOI:...